Clinical trial
An Exploratory Study of Nesiritide in Participants With Acute Heart Failure
NCT00490724 · Janssen Pharmaceutical K.K., Industry · Completed
Key facts
| NCT number | NCT00490724 |
|---|---|
| Title | An Exploratory Study of Nesiritide in Participants With Acute Heart Failure |
| Official title | An Exploratory Study of JNS004 (Nesiritide) in Patients With Acute Heart Failure (J2) |
| Lead sponsor | Janssen Pharmaceutical K.K., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | Nesiritide (1+0.01), Nesiritide (2+0.005), Nesritide (2+0.01) |
| Enrollment | 67 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 25, 2007 |
| Last update posted | Feb 3, 2014 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: